These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13158)

  • 1. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of LSD and BOL on the catecholamine synthesis and turnover in various brain regions.
    Persson SA
    Psychopharmacology (Berl); 1978 Oct; 59(2):113-6. PubMed ID: 31650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine levels and tyrosine hydroxylase activities in rat brain regions after chronic treatment with, and withdrawal of, methamphetamine.
    Bardsley ME; Bachelard HS
    Biochem Pharmacol; 1981 Jun; 30(12):1543-9. PubMed ID: 6115646
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of catecholamine synthesis in rat brain synaptosomes.
    Patrick RL; Barchas JD
    J Neurochem; 1974 Jul; 23(1):7-15. PubMed ID: 4153038
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
    Peters DA
    Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
    [No Abstract]   [Full Text] [Related]  

  • 6. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of some psychotropic drugs on tyrosine hydroxylase activity in different structures of the rat brain.
    Besson MJ; Cheramy A; Gauchy C; Musacchio J
    Eur J Pharmacol; 1973 May; 22(2):181-6. PubMed ID: 4146008
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of endogenous catecholamines from isolated rat brain tissue by fenfluramine and N-ethylamphetamine--effects of pargyline.
    Tessel RE; Burgess SK; Rutledge CO
    Biochem Pharmacol; 1978; 27(12):1631-6. PubMed ID: 697904
    [No Abstract]   [Full Text] [Related]  

  • 9. Catecholamine concentrations and the activity of tyrosine hydroxylase after an increase in the concentration of tyrosine in rat tissues.
    Dairman W
    Br J Pharmacol; 1972 Feb; 44(2):307-10. PubMed ID: 4148919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accumulation of p-hydroxyamphetamine by brain homogenates and its role in the release of catecholamines.
    Cho AK; Fischer JF; Schaeffer JC
    Biochem Pharmacol; 1977 Aug; 26(15):1367-72. PubMed ID: 901551
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of perinatal undernutrition on the metabolism of catecholamines in the rat brain.
    Shoemaker WJ; Wurtman RJ
    J Nutr; 1973 Nov; 103(11):1537-47. PubMed ID: 4148058
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge.
    Masana MI; Heyes MP; Mefford IN
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):609-21. PubMed ID: 2236587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.
    Stolk JM; Barchas JD; Goldstein M; Boggan W; Freedman DX
    J Pharmacol Exp Ther; 1974 Apr; 189(1):42-50. PubMed ID: 4823298
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors.
    Prada MD; Saner A; Burkark WP; Bartholini G; Pletscher A
    Brain Res; 1975 Aug; 94(1):67-73. PubMed ID: 1148867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD: effect on monoamine metabolites in rat prefrontal cortex.
    Bowers MB; Salomonsson LA
    Biochem Pharmacol; 1982 Dec; 31(24):4093-6. PubMed ID: 6186259
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
    Fuxe K; Fredholm BB; Agnati LF; Ogren SO; Everitt BJ; Jonsson G; Gustafsson JA
    Pharmacology; 1978; 16 Suppl 1():99-134. PubMed ID: 643908
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of tyrosine in the acute effects of ethanol on rat brain catecholamine synthesis.
    Badawy AA; Williams DL; Evans M
    Pharmacol Biochem Behav; 1983; 18 Suppl 1():389-96. PubMed ID: 6138774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
    Tseng LF; Hitzemann RJ; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.